Work

Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer

Year: 2026

Type: preprint

Study design: Clinical Trial

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.6036075

Authors: Julia Whitman, Chloe E. Attreya, Andrea Bocobo, Bridget Patrice Keenan, Kelvin Koser, Wesley A. Kidder, Sorbarikor Piawah, Katherine Van Loon, Spencer C. Behr, K. Pallav Kolli, Xiaoying Chen, Courtney Onodera, Manjusha Pande, Marin Pollak, Renee Wang, Joel Babdor, Matthew H. Spitzer, Li Zhang, Lawrence Fong

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of Pennsylvania, Gladstone Institutes, Parker Institute for Cancer Immunotherapy, Stanford University

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7123808564

Cites:

Cited by: 1

Related to: